Infarmed has ordered the marketing suspension and withdrawal from the market of two cannabidiol creams whose use is prohibited in cosmetic products, the medicines authority said.
Information available on the Infarmed website explains that the decision was made based on a complaint received regarding Cannabiron CBD creams from Dietmed and Good Cannabis from Vitaceutics.
The National Drugs and Health Products Administration withdraws the 2022 circular on the use of cannabis and its derivatives in cosmetic products.
It is also explained that the creams in question contain cannabidiol, which is obtained through extracts or tinctures of hemp or its resin and is not allowed in cosmetic products.
“Organizations that have these products should not make them available,” and consumers who have these products “should not use them,” Infarmed recommends.
Author: Lusa
Source: CM Jornal
I’m Dave Martin, and I’m an experienced journalist working in the news industry. As a part of my work, I write for 24 News Reporters, covering mostly sports-related topics. With more than 5 years of experience as a journalist, I have written numerous articles on various topics to provide accurate information to readers.